The present invention relates to a method of preparing an oxidatively curable coating formulation made from an oxidatively curable alkyd-based resin, a complex comprising one or more manganese ions and one or more triazacyclononane-based ligands; and to the use of triazacyclononane-based ligands for accelerating the rate of curing of an alkyd-based resin formulation by such complexes. The formulations may be paints or other oxidatively curable coating compositions.

The present invention relates to a method of preparing an oxidatively curable coating formulation made from an oxidatively curable alkyd-based resin, a complex comprising one or more manganese ions and one or more triazacyclononane-based ligands; and to the use of triazacyclononane-based ligands for accelerating the rate of curing of an alkyd-based resin formulation by such complexes. The formulations may be paints or other oxidatively curable coating compositions.

The present disclosure relates to a catalyst system to produce crystallizable polyester compositions which comprise residues of terephthalic acid, neopentyl glycol (NRG), 1,4-cyclohexanedimethanol (CHDM), ethylene glycol (EG), and diethylene glycol (DEG), in certain compositional ranges having certain advantages and improved properties including recyclability. The present disclosure also relates to a catalyst system to produce crystallizable polyester compositions which comprise residues of recycled terephthalic acid, recycled neopentyl glycol (NRG), recycled 1,4-cyclohexanedimethanol (CHDM), recycled ethylene glycol (EG), and/or recycled diethylene glycol (DEG), in certain compositional ranges having certain advantages and improved properties including recyclability.

A semicrystalline plastic composition comprising: a semicrystalline plastic and an additive dispersed therein. The semicrystalline plastic includes a polymeric chain comprising repeat units of an oligomeric or polymeric chain and the additive comprises a supramolecular building block and an oligomeric or polymeric tail. The oligomeric or polymeric tail of the additive having the same repeat units as the polymeric chain of the semicrystalline plastic. The additive forming a plurality of sheet-like structures through hydrogen bonding. The sheet-like structures, interacting through non-covalent interaction, form crystallized additive domains within the semicrystalline plastic.

The present invention relates to aqueous alkyd resin dispersions comprising a) a short oil alkyd resin comprising, in its fatty acid component a1), at least one polyunsaturated fatty monoacid a11) having at least two unsaturations per molecule and comprising at least 35% by weight of a monoacid a111) having conjugated unsaturations, the content by weight of said fatty monoacid a111), with respect to said alkyd resin, being at least 5%, preferably from 5% to 40% and more preferably from 5% to 35%, and b) at least one anionic phosphate surfactant. The invention also covers a preparation process and its use in decorative coatings. The coatings based on these aqueous dispersions exhibit improved performance qualities in resistance to blocking and yellowing, in development of hardness and in gloss.

An end and monomer functionalized poly(propylene fumarate) polymer and methods for preparing this polymer, comprising isomerized residue of a maleic anhydride monomer and a functionalized propylene oxide monomer according to the formula: ##STR00001## where n is an integer from more than 1 to 100; R is the residue of an initiating alcohol having a propargyl, norbornene, ketone or benzyl functional group; and R′ is a second functional group selected from the group consisting of propargyl groups, 2-nitrophenyl groups, and combinations thereof are disclosed. The end and monomer functional groups allow for post-polymerization modification with bioactive materials using “click” chemistries and use of the polymer for a variety of applications in medical fields, including, for example, 3-D printed polymer scaffold.

An end and monomer functionalized poly(propylene fumarate) polymer and methods for preparing this polymer, comprising isomerized residue of a maleic anhydride monomer and a functionalized propylene oxide monomer according to the formula: ##STR00001## where n is an integer from more than 1 to 100; R is the residue of an initiating alcohol having a propargyl, norbornene, ketone or benzyl functional group; and R′ is a second functional group selected from the group consisting of propargyl groups, 2-nitrophenyl groups, and combinations thereof are disclosed. The end and monomer functional groups allow for post-polymerization modification with bioactive materials using “click” chemistries and use of the polymer for a variety of applications in medical fields, including, for example, 3-D printed polymer scaffold.

The disclosure relates to methods of making foams comprising aromatic polyester polyether polyol materials derived from the transesterification of polyethylene terephthalate with either glycerin or trimethylolpropane, wherein each of these triols, independently, has a degree of ethoxylation of from 1 to 9. Uses of the foams are further disclosed. The disclosure further relates to selection of blowing agents suitable to generate a selected end use case. Yet further, the disclosure relates to selection of end uses, properties, and environmental profiles of the foams generated according to the methods herein, and selecting formulation variables suitable to obtain the foams.

The present invention relates to the combination of certain flame retardant additives in a copolyester to improve the flame retardant properties of the copolyester composition while retaining clarity and impact properties, methods of making the copolyester composition and articles made from the copolyester composition. More specifically, the present invention relates to the use of brominated flame retardant compounds in copolyester compositions to improve the flame retardant properties while surprisingly retaining clarity, glass transition temperature, and impact properties.

Embodiments of the invention concern copolymers and nanoparticles for use as delivery agents for one or more agents for therapy for a medical condition of humans and animals. Some of embodiments of the invention provide new reagents for biomedical research in cell culture, animal models and plants, for example. The copolymers comprise PLGA and PEI and, in some embodiments, also comprise 1-(3-aminopropyl)-4-methylpiperazine (APMP), Fc binding peptide and/or antibody. In certain embodiments, APMP-PLGA-PEI, Fc binding peptide/antibody-PLGA-PEI or Fc binding peptide/antibody-APMP-PLGA-PEI nanoparticles comprising one or more therapeutic agents are delivered to an individual in need thereof or used for biomedical research in cell cultures, animal models and plants.